Literature DB >> 15127386

Effect of fibrous capsule formation on doxorubicin distribution in radiofrequency ablated rat livers.

Elvin Blanco1, Feng Qian, Brent Weinberg, Nicholas Stowe, James M Anderson, Jinming Gao.   

Abstract

In this study, we report the histological findings of a combined therapy using radiofrequency ablation and intratumoral drug delivery in rat livers, with special attention to wound-healing processes and their effects on drug transport in post-ablated tissue. Doxorubicin-loaded millirods were implanted in rat livers that had undergone medial lobe ablation. Millirods and liver samples were retrieved upon animal sacrifice at time points ranging from 1 h to 8 days. Results demonstrate a clearly defined area of coagulative necrosis within the ablation boundary. The wound-healing response, complete with the appearance of inflammatory cells, neovascularization, and the formation of a fibrous capsule, was also observed. At the 8-day time point, fluorescence imaging analysis showed a higher concentration of doxorubicin localized within the ablation region, with its distribution hampered primarily by fibrous capsule formation at the boundary. Given the variant nature of ablated liver, a mathematical model devised previously by our laboratory describes the data well up to 4 days, but loses reliability at 8 days. These results provide useful mechanistic insights into the wound-healing response after radiofrequency ablation and polymer millirod implantation, as well as the impact this natural corollary has on drug distribution. Copyright 2004 Wiley Periodicals, Inc. J Biomed Mater Res 69A: 398-406, 2004

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15127386     DOI: 10.1002/jbm.a.30001

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  7 in total

1.  Species and density of implant surface chemistry affect the extent of foreign body reactions.

Authors:  Ashwin Nair; Ling Zou; Dhiman Bhattacharyya; Richard B Timmons; Liping Tang
Journal:  Langmuir       Date:  2008-01-12       Impact factor: 3.882

2.  Radiofrequency ablation of small hepatocellular carcinoma with intravenous pegylated liposomal doxorubicin.

Authors:  Jing-Houng Wang; Hung-Da Tung; Tai-Yi Chen; Chao-Hung Hung; Chien-Hung Chen; Chi-Sin Changchien; Tsung-Hui Hu; Chuan-Mo Lee; Sheng-Nan Lu
Journal:  Hepatol Int       Date:  2010-09-18       Impact factor: 6.047

Review 3.  Clinical Pharmacokinetics and Pharmacodynamics of Transarterial Chemoembolization and Targeted Therapies in Hepatocellular Carcinoma.

Authors:  Anne Hulin; Jeanick Stocco; Mohamed Bouattour
Journal:  Clin Pharmacokinet       Date:  2019-08       Impact factor: 6.447

4.  Dynamic actuation enhances transport and extends therapeutic lifespan in an implantable drug delivery platform.

Authors:  William Whyte; Debkalpa Goswami; Sophie X Wang; Yiling Fan; Niamh A Ward; Ruth E Levey; Rachel Beatty; Scott T Robinson; Declan Sheppard; Raymond O'Connor; David S Monahan; Lesley Trask; Keegan L Mendez; Claudia E Varela; Markus A Horvath; Robert Wylie; Joanne O'Dwyer; Daniel A Domingo-Lopez; Arielle S Rothman; Garry P Duffy; Eimear B Dolan; Ellen T Roche
Journal:  Nat Commun       Date:  2022-08-03       Impact factor: 17.694

5.  Magnetic resonance thermal imaging combined with SMASH navigators in the presence of motion.

Authors:  Youngseob Seo; Jacob Willig-Onwuachi; Jeffrey H Walton
Journal:  J Appl Clin Med Phys       Date:  2012-07-05       Impact factor: 2.102

Review 6.  Advanced strategies to thwart foreign body response to implantable devices.

Authors:  Simone Capuani; Gulsah Malgir; Corrine Ying Xuan Chua; Alessandro Grattoni
Journal:  Bioeng Transl Med       Date:  2022-03-02

7.  Surgical and Pathological Changes after Radiofrequency Ablation of Thyroid Nodules.

Authors:  Chiara Dobrinja; Stella Bernardi; Bruno Fabris; Rita Eramo; Petra Makovac; Gabriele Bazzocchi; Lanfranco Piscopello; Enrica Barro; Nicolò de Manzini; Deborah Bonazza; Maurizio Pinamonti; Fabrizio Zanconati; Fulvio Stacul
Journal:  Int J Endocrinol       Date:  2015-07-21       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.